Your session is about to expire
← Back to Search
Hemostatic Agent
Treatment with XSTAT for Bleeding (PhoXSTAT Trial)
N/A
Waitlist Available
Led By Jan Jansen, MBBS, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Penetrating junctional injury (femoral or axillary), with i. visible bleeding ii. too proximal to be controlled with a tourniquet
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 29 months
Awards & highlights
PhoXSTAT Trial Summary
This trialtests a device to help stop severe bleeding in emergency situations. Participants will get either the device or standard care.
Eligible Conditions
- Bleeding
- Hemorrhagic Shock
- Penetrating Injury
PhoXSTAT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You have a serious injury in your thigh or armpit that is bleeding heavily and cannot be stopped with a tourniquet.
PhoXSTAT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through 29 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 29 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adverse events from use of XSTAT device
Ease of use of XSTAT device by EMS personnel
Incidence of patients with hemorrhage from junctional wounds
+12 morePhoXSTAT Trial Design
2Treatment groups
Experimental Treatment
Group I: Treatment with XSTATExperimental Treatment1 Intervention
Participants randomized to the treatment arm will be treated using the study device - XSTAT.
Group II: Standard CareExperimental Treatment1 Intervention
Participants assigned to the control group receive standard prehospital care, consisting of direct pressure/dressings.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,565 Previous Clinical Trials
2,268,357 Total Patients Enrolled
Jan Jansen, MBBS, PhDPrincipal InvestigatorThe University of Alabama at Birmingham
1 Previous Clinical Trials
1,100 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new participants being sought for this clinical experiment?
"The research posted on clinicaltrials.gov suggests that the trial, first listed on October 29th 2022, is still accepting participants. The researchers are seeking 50 individuals to participate in their study at a single site."
Answered by AI
What is the participant count for this experiment?
"Affirmative. Information published on clinicaltrials.gov indicates that this trial, which commenced recruiting patients on October 29th 2022, still actively seeking participants. A total of 50 individuals are required from one medical facility for data collection purposes."
Answered by AI
Share this study with friends
Copy Link
Messenger